COMBAT: A study of 64 Cu-SAR-BBN and 67 Cu-SAR-BBN for identification and treatment of GRPr-expressing metastatic castrate-resistant prostate cancer.
- Resource Type
- Article
- Source
- Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, pTPS247-TPS247, 235p
- Subject
- Language
- ISSN
- 0732183X